{"id":304,"date":"2020-03-29T22:25:19","date_gmt":"2020-03-29T22:25:19","guid":{"rendered":"http:\/\/bxta-staging.website\/?page_id=304"},"modified":"2021-09-14T22:02:19","modified_gmt":"2021-09-14T22:02:19","slug":"gp-information","status":"publish","type":"page","link":"https:\/\/bxta.com\/uk\/healthcare-professionals\/gp-information\/","title":{"rendered":"GP Information"},"content":{"rendered":"\n<style>\n.hero-banner .ll-cta-banner__inner {\n  padding-top: 140px;\n  padding-bottom: 140px;\n}\n.hero-banner .ll-cta-banner__heading {\n  color: #03843e;\n}\n.top-space {\n display:none;\n}\n.ll-text-block {\n  padding: 40px 30px;\n}\n.ll-text-block .ll-text-block__heading {\n  color: #FFFFFF !important;\n  font-size: 2.4375rem;\n  line-height: 2.8125rem;\n}\n.ll-text-block .ll-text-block__text-entry p {\n  color: #FFFFFF !important;\n  font-weight:200!important;\n}\n.wp-block-column ul li a {\n  color: #03843e;\n}\n<\/style>\n\n\n\n<div class=\"wp-block-cgb-block-ll-banner ll-row undefined hero-banner\"><div class=\"ll-cta-banner \"><div class=\"ll-cta-banner__image\" style=\"background-image:url(https:\/\/bxta.com\/wp-content\/uploads\/2021\/05\/Screenshot-2021-05-07-at-11.56.37.png)\"><\/div><div class=\"ll-cta-banner__inner\"><div class=\"ll-cta-banner__headings\"><h2 class=\"ll-cta-banner__heading\"><\/h2><\/div><div class=\"ll-cta-banner__content\"><div class=\"ll-cta-banner__buttons\"><\/div><\/div><\/div><\/div><\/div>\n\n\n\n<div id=\"\" class=\"wp-block-cgb-block-ll-content-block ll-row ll-row--med\"><div class=\"ll-content\"><div class=\"ll-content__inner\">\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-cgb-block-ll-innerblock-heading\"><div class=\"ll-headings  \"><h3 class=\"ll-heading ll-heading--lrg\" style=\"color:#03843e\">GP Information<\/h3><\/div><\/div>\n\n\n\n<p>This section of the website is designed for GPs to provide an update on the developments in Brachytherapy for localised prostate cancer and what this means for GPs and their patients.<\/p>\n<\/div><\/div><\/div>\n\n\n\n<div class=\"wp-block-cgb-ll-text ll-row ll-row--med\" style=\"background-color:#03843e\"><div class=\"ll-text-block ll-text--center\"><div class=\"ll-text-block__inner\"><div class=\"ll-text-block__headings\"><h3 class=\"ll-text-block__heading\" style=\"color: #ffffff\">The influential role of GPs and brachytherapy in prostate cancer care<\/h3><\/div><div class=\"ll-text-block__text-entry\"><p style=\"color: #ffffff\">The article discusses how LDR monotherapy is an excellent alternative to surgery in patients with low and favourable intermediate risk PC (Durable PSA, RFS and Low toxicity), and looks at the critical role GPs play in ensuring patients have access to a range of treatment options when diagnosed with Prostate Cancer.<\/p><\/div><div class=\"ll-text-block__buttons\"><a href=\"\/The-influential-role-of-GPs\" class=\"ll-button ll-button--secondary\" title=\"Read More\" rel=\"noopener\">Read More<\/a><\/div><\/div><\/div><\/div>\n\n\n\n<div id=\"\" class=\"wp-block-cgb-block-ll-content-block ll-row ll-row--med\"><div class=\"ll-content\"><div class=\"ll-content__inner\">\n<p><strong>Find out more:<\/strong><\/p>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<ul class=\"wp-block-list\"><li><a href=\"https:\/\/www.bxt-accelyon.com\/prostate-cancer--the-facts\">Prostate cancer:<\/a><a href=\"\/patient-information\/prostate-cancer-the-facts\/\"> <\/a><a href=\"\/prostate-cancer--the-facts\">The facts<\/a><\/li><li><a href=\"\/patient-information\/is-ldr-brachytherapy-right-for-me\/\">Is brachytherapy right for me?<\/a><\/li><li><a href=\"\/pcrsg-study\">PCRSG study<\/a><\/li><li><a href=\"\/healthcare-professionals\/resources\/\">Resources<\/a><\/li><\/ul>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<ul class=\"wp-block-list\"><li><a href=\"https:\/\/www.bxt-accelyon.com\/ascende-rt-study\"><\/a><a href=\"\/ascende-rt-study\">ASCENDE-RT study<\/a><\/li><li><a href=\"\/patient-information\/what-is-ldr-brachytherapy\/\"><\/a><a href=\"\/what-is-ldr-brachytherapy\">What is LDR brachytherapy?<\/a><\/li><li><a href=\"\/treatment-centres\/\"><\/a><a href=\"\/treatment-centres\">Treatment centres<\/a><\/li><li><a href=\"https:\/\/www.linkedin.com\/organization\/9498863\"><\/a><a rel=\"noreferrer noopener\" href=\"https:\/\/www.linkedin.com\/organization\/9498863\" target=\"_blank\">Follow BXTAccelyon on LinkedIn<\/a><\/li><\/ul>\n<\/div>\n<\/div>\n<\/div><\/div><\/div>\n\n\n\n<div id=\"\" class=\"wp-block-cgb-block-ll-content-block ll-row ll-row--med\"><div class=\"ll-content\"><div class=\"ll-content__inner\">\n<p><strong>Find out more:<\/strong><\/p>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<h4 class=\"has-c-primary-color has-text-color wp-block-heading\">What is LDR brachytherapy?<\/h4>\n\n\n\n<p>Low-dose rate (LDR) brachytherapy is a type of internal radiation therapy that delivers radiation at a low-dose rate from implants placed permanently in the prostate.<\/p>\n\n\n\n<p>Brachytherapy is a type of radiotherapy, or radiation treatment. Radiotherapy uses gamma- or x-rays to treat cancer. The radiation involved is much stronger than that used for an ordinary x-ray picture. There are two types of brachytherapy &#8211; high dose-rate (HDR) and low dose-rate (LDR). LDR brachytherapy is the type that is most commonly used to treat prostate cancer; it may sometimes be referred to as &#8216;seed implantation&#8217;.<\/p>\n\n\n\n<p><a href=\"https:\/\/www.bxt-accelyon.com\/what-is-ldr-brachytherapy\">Click here&nbsp;<\/a>to find out more about brachytherapy including; clinics, treatment process, possible side effects, aftercare and&nbsp;recovery process.<\/p>\n\n\n\n<div id=\"\" class=\"wp-block-cgb-block-ll-buttons ll-row default\"><div class=\"ll-buttons-row\">\n<div class=\"ll-inline\" class=\"wp-block-cgb-block-ll-innerblock-button\"><a href=\"\/patient-information\/what-is-ldr-brachytherapy\/\" id=\"\" class=\"ll-button default  \">Learn More<\/a><\/div>\n<\/div><\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<h4 class=\"has-c-primary-color has-text-color wp-block-heading\">Treatment information<\/h4>\n\n\n\n<p>LDR brachytherapy uses radioactive seeds bound together in short rows and permanently implants them into the prostate. These pellets emit low levels of radiation for several weeks. When this radiation treatment ends, the harmless seeds are left in place permanently.&nbsp;<\/p>\n\n\n\n<p>Primarily used to treat prostate cancer, LDR brachytherapy is a one-time procedure. The procedure itself generally takes about an hour.<\/p>\n\n\n\n<p>Brachytherapy offers a quicker, more effective type of radiation treatment for some patients. Depending on the type and stage of cancer, brachytherapy may be combined with other treatments, which can vary treatment times.&nbsp;<\/p>\n\n\n\n<div id=\"\" class=\"wp-block-cgb-block-ll-buttons ll-row default\"><div class=\"ll-buttons-row\">\n<div class=\"ll-inline\" class=\"wp-block-cgb-block-ll-innerblock-button\"><a href=\"\/patient-information\/what-is-ldr-brachytherapy\/\" id=\"\" class=\"ll-button ll-button--secondary  \">Learn More<\/a><\/div>\n<\/div><\/div>\n<\/div>\n<\/div>\n<\/div><\/div><\/div>\n\n\n\n<div class=\"ll-posts--latest post--has-3\">\n  \n  <div class=\"ll-posts__inner\">\n    <div class=\"ll-posts__headings\">\n      <h3 class=\"ll-posts__heading\">Latest News<\/h3>\n    <\/div>\n    <div class=\"ll-posts__feed\">\n    \n      <a href=\"https:\/\/bxta.com\/uk\/advancing-prostate-cancer-diagnosis-bxta-and-australian-government-unite-to-drive-mens-health-innovation\/\" title=\"blog post title here\" rel=\"noopener\" class=\"ll-post\">\n        <div class=\"ll-post__inner\">\n          <div class=\"ll-post__image\" style=\"background-image: url(https:\/\/bxta.com\/wp-content\/uploads\/2025\/10\/BXTA-at-Australian-Parliamentary-Roundtable.jpg)\"><\/div>\n          <div class=\"ll-post__content\">\n            <div class=\"ll-post__date\">October 31, 2025<\/div>\n            <div class=\"ll-post__title\">\n              Advancing Prostate Cancer Diagnosis: BXTA and Australian Government Unite to Drive Men\u2019s Health Innovation            <\/div>\n          <\/div>\n        <\/div>\n      <\/a>\n      \n    \n      <a href=\"https:\/\/bxta.com\/uk\/celebrating-nurse-led-innovation-in-prostate-cancer-diagnosis-at-eaun25\/\" title=\"blog post title here\" rel=\"noopener\" class=\"ll-post\">\n        <div class=\"ll-post__inner\">\n          <div class=\"ll-post__image\" style=\"background-image: url(https:\/\/bxta.com\/wp-content\/uploads\/2025\/04\/2025.03.24-Grace-Zisengwe-Award-1.jpg)\"><\/div>\n          <div class=\"ll-post__content\">\n            <div class=\"ll-post__date\">April 24, 2025<\/div>\n            <div class=\"ll-post__title\">\n              Celebrating Nurse-led Innovation in Prostate Cancer Diagnosis at EAUN25            <\/div>\n          <\/div>\n        <\/div>\n      <\/a>\n      \n    \n      <a href=\"https:\/\/bxta.com\/uk\/becoming-a-centre-of-excellence-for-la-tp-prostate-biopsy\/\" title=\"blog post title here\" rel=\"noopener\" class=\"ll-post\">\n        <div class=\"ll-post__inner\">\n          <div class=\"ll-post__image\" style=\"background-image: url(https:\/\/bxta.com\/wp-content\/uploads\/2023\/03\/AdobeStock_321234696.jpeg)\"><\/div>\n          <div class=\"ll-post__content\">\n            <div class=\"ll-post__date\">December 1, 2023<\/div>\n            <div class=\"ll-post__title\">\n              <strong>Barking, Havering and Redbridge University Hospitals NHS Trust: becoming a Centre of Excellence for LA TP Prostate Biopsy with Antibiotic Stewardship<\/strong>            <\/div>\n          <\/div>\n        <\/div>\n      <\/a>\n      \n        <\/div>\n  <\/div>\n<\/div>\n\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":306,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-304","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Information for GP&#039;s - BXTA<\/title>\n<meta name=\"description\" content=\"Updates on the developments in Brachytherapy for localised prostate cancer and what this means for you and your patients.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bxta.com\/uk\/healthcare-professionals\/gp-information\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Information for GP&#039;s - BXTA\" \/>\n<meta property=\"og:description\" content=\"Updates on the developments in Brachytherapy for localised prostate cancer and what this means for you and your patients.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bxta.com\/uk\/healthcare-professionals\/gp-information\/\" \/>\n<meta property=\"og:site_name\" content=\"BXTA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/bxtainternational\/\" \/>\n<meta property=\"article:modified_time\" content=\"2021-09-14T22:02:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bxta.com\/wp-content\/uploads\/2021\/05\/BXTA-2-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1480\" \/>\n\t<meta property=\"og:image:height\" content=\"1046\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@BXTA_\" \/>\n<meta name=\"twitter:label1\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/healthcare-professionals\\\/gp-information\\\/\",\"url\":\"https:\\\/\\\/bxta.com\\\/uk\\\/healthcare-professionals\\\/gp-information\\\/\",\"name\":\"Information for GP's - BXTA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/#website\"},\"datePublished\":\"2020-03-29T22:25:19+00:00\",\"dateModified\":\"2021-09-14T22:02:19+00:00\",\"description\":\"Updates on the developments in Brachytherapy for localised prostate cancer and what this means for you and your patients.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/healthcare-professionals\\\/gp-information\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/bxta.com\\\/uk\\\/healthcare-professionals\\\/gp-information\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/healthcare-professionals\\\/gp-information\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/bxta.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Healthcare Professionals\",\"item\":\"https:\\\/\\\/bxta.com\\\/uk\\\/healthcare-professionals\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"GP Information\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/#website\",\"url\":\"https:\\\/\\\/bxta.com\\\/uk\\\/\",\"name\":\"BXTA\",\"description\":\"Let\u2019s tackle Prostate Cancer together | BXTA\",\"publisher\":{\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/bxta.com\\\/uk\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/#organization\",\"name\":\"BXTA\",\"url\":\"https:\\\/\\\/bxta.com\\\/uk\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/bxta-staging.s3.eu-west-2.amazonaws.com\\\/app\\\/uploads\\\/2021\\\/09\\\/07212056\\\/BXTA-Logo.png\",\"contentUrl\":\"https:\\\/\\\/bxta-staging.s3.eu-west-2.amazonaws.com\\\/app\\\/uploads\\\/2021\\\/09\\\/07212056\\\/BXTA-Logo.png\",\"width\":600,\"height\":373,\"caption\":\"BXTA\"},\"image\":{\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/bxtainternational\\\/\",\"https:\\\/\\\/x.com\\\/BXTA_\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/bxtaccelyon\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCkTU9L10CS5c1eWtGiMZ7gw\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Information for GP's - BXTA","description":"Updates on the developments in Brachytherapy for localised prostate cancer and what this means for you and your patients.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bxta.com\/uk\/healthcare-professionals\/gp-information\/","og_locale":"en_GB","og_type":"article","og_title":"Information for GP's - BXTA","og_description":"Updates on the developments in Brachytherapy for localised prostate cancer and what this means for you and your patients.","og_url":"https:\/\/bxta.com\/uk\/healthcare-professionals\/gp-information\/","og_site_name":"BXTA","article_publisher":"https:\/\/www.facebook.com\/bxtainternational\/","article_modified_time":"2021-09-14T22:02:19+00:00","og_image":[{"width":1480,"height":1046,"url":"https:\/\/bxta.com\/wp-content\/uploads\/2021\/05\/BXTA-2-scaled.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@BXTA_","twitter_misc":{"Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/bxta.com\/uk\/healthcare-professionals\/gp-information\/","url":"https:\/\/bxta.com\/uk\/healthcare-professionals\/gp-information\/","name":"Information for GP's - BXTA","isPartOf":{"@id":"https:\/\/bxta.com\/uk\/#website"},"datePublished":"2020-03-29T22:25:19+00:00","dateModified":"2021-09-14T22:02:19+00:00","description":"Updates on the developments in Brachytherapy for localised prostate cancer and what this means for you and your patients.","breadcrumb":{"@id":"https:\/\/bxta.com\/uk\/healthcare-professionals\/gp-information\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bxta.com\/uk\/healthcare-professionals\/gp-information\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/bxta.com\/uk\/healthcare-professionals\/gp-information\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bxta.com\/"},{"@type":"ListItem","position":2,"name":"Healthcare Professionals","item":"https:\/\/bxta.com\/uk\/healthcare-professionals\/"},{"@type":"ListItem","position":3,"name":"GP Information"}]},{"@type":"WebSite","@id":"https:\/\/bxta.com\/uk\/#website","url":"https:\/\/bxta.com\/uk\/","name":"BXTA","description":"Let\u2019s tackle Prostate Cancer together | BXTA","publisher":{"@id":"https:\/\/bxta.com\/uk\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/bxta.com\/uk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/bxta.com\/uk\/#organization","name":"BXTA","url":"https:\/\/bxta.com\/uk\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/bxta.com\/uk\/#\/schema\/logo\/image\/","url":"https:\/\/bxta-staging.s3.eu-west-2.amazonaws.com\/app\/uploads\/2021\/09\/07212056\/BXTA-Logo.png","contentUrl":"https:\/\/bxta-staging.s3.eu-west-2.amazonaws.com\/app\/uploads\/2021\/09\/07212056\/BXTA-Logo.png","width":600,"height":373,"caption":"BXTA"},"image":{"@id":"https:\/\/bxta.com\/uk\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/bxtainternational\/","https:\/\/x.com\/BXTA_","https:\/\/www.linkedin.com\/company\/bxtaccelyon","https:\/\/www.youtube.com\/channel\/UCkTU9L10CS5c1eWtGiMZ7gw"]}]}},"_links":{"self":[{"href":"https:\/\/bxta.com\/uk\/wp-json\/wp\/v2\/pages\/304","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bxta.com\/uk\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/bxta.com\/uk\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/bxta.com\/uk\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bxta.com\/uk\/wp-json\/wp\/v2\/comments?post=304"}],"version-history":[{"count":44,"href":"https:\/\/bxta.com\/uk\/wp-json\/wp\/v2\/pages\/304\/revisions"}],"predecessor-version":[{"id":3077,"href":"https:\/\/bxta.com\/uk\/wp-json\/wp\/v2\/pages\/304\/revisions\/3077"}],"up":[{"embeddable":true,"href":"https:\/\/bxta.com\/uk\/wp-json\/wp\/v2\/pages\/306"}],"wp:attachment":[{"href":"https:\/\/bxta.com\/uk\/wp-json\/wp\/v2\/media?parent=304"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}